Skip to main content
DBD $67.84 +0.40%
DBD logo
DBD · DIEBOLD NIXDORF, Inc
Track DBD — free
$67.84 +0.27 (+0.40%) At close · Oct 20
Market Cap
$2.30B
Shares
33.95M
Volume · Oct 20 167.16K Avg daily vol (3M) 262.92K
All webcasts

Earnings call · FY2021 Q4

DIEBOLD NIXDORF, Inc (DBD) Q4 2021 Earnings Call

Concluded Feb 10, 2022
Feb 10, 2022 0 turns
Period
FY2021 Q4
Runtime
—
Sources
2 artifacts
Revenue · derived Q4 $1.06B -4.2% YoY
Gross margin · derived Q4 24.4% -0.6 pp YoY
Net income · derived Q4 -$38.30M
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Forward guidance

4 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Feb 10, 2022.

Metric Guided Actual
Total Revenue
Full-year 2022
$4B – $4.2B $3.46B below
Adjusted EBITDA (non-GAAP measure) table
Full-year 2022
$440M – $460M —
Free cash flow (non-GAAP measure) table
Full-year 2022
$130M – $150M —
Return on Invested Capital (non-GAAP measure) table
Full-year 2022
17% —
Full-screen source Call document